Get startedLog in
    Picture of Mankind Pharma logo

    MANKIND — Mankind Pharma Cashflow Statement

    0.000.00%
    in flag iconLast trade - 00:00
    HealthcareBalancedLarge CapHigh Flyer
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual cashflow statement for Mankind Pharma, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

    2022
    March 31st
    2023
    March 31st
    2024
    March 31st
    2025
    March 31st
    2026
    March 31st
    Period Length:12 M12 M12 M12 M12 M
    Source:ARSARSARSARSPRESS
    Standards:
    IAS
    IAS
    IAS
    IAS    		—
    Status:FinalFinalFinalFinalFinal
    Net Income/Starting Line19,74616,71223,99425,16323,327
    Depreciation
    Non-Cash Items-1,358-275-1,860-2043,894
    Discontinued Operations
    Unusual Items
    Equity in Net Earnings/Losses
    Other Non-Cash Items
    Changes in Working Capital-10,856-1,564-4,591-6,462-4,869
    Change in Accounts Receivable
    Change in Inventories
    Change in Other Assets
    Change in Accounts Payable
    Change in Other Liabilities
    Other Operating Cash Flow
    Cash from Operating Activities9,19818,13321,52424,71031,213
    Capital Expenditures-23,455-8,321-3,892-5,308-7,372
    Purchase of Fixed Assets
    Purchase / Acquisition of Intangibles
    Other Investing Cash Flow Items9,764-2,221-16,925-121,5225,408
    Acquisition of Business
    Sale of Fixed Assets
    Sale/Maturity of Investment
    Change in Net Investments
    Purchase of Investments
    Other Investing Cash Flow
    Cash from Investing Activities-13,691-10,541-20,817-126,830-1,964
    Financing Cash Flow Items-178-419-262-981-6,690
    Other Financing Cash Flow
    Total Cash Dividends Paid
    Net Issuance / Retirement of Stock
    Net Issuance / Retirement of Debt
    Cash from Financing Activities6,046-7,39752.7102,326-29,527
    Foreign Exchange Effects
    Beginning Cash Balance
    Ending Cash Balance
    Net Change in Cash1,557218772219-122